Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
212.29
+3.02 (1.44%)
Apr 8, 2026, 1:08 PM EDT - Market open
Natera Employees
Natera had 6,140 employees as of December 31, 2025. The number of employees increased by 1,706 or 38.48% compared to the previous year.
Employees
6,140
Change (1Y)
1,706
Growth (1Y)
38.48%
Revenue / Employee
$375,588
Profits / Employee
-$33,902
Market Cap
30.09B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6,140 | 1,706 | 38.48% |
| Dec 31, 2024 | 4,434 | 1,141 | 34.65% |
| Dec 31, 2023 | 3,293 | 275 | 9.11% |
| Dec 31, 2022 | 3,018 | 348 | 13.03% |
| Dec 31, 2021 | 2,670 | 855 | 47.11% |
| Dec 31, 2020 | 1,815 | 776 | 74.69% |
| Dec 31, 2019 | 1,039 | 64 | 6.56% |
| Dec 31, 2018 | 975 | 82 | 9.18% |
| Dec 31, 2017 | 893 | 41 | 4.81% |
| Dec 31, 2016 | 852 | 136 | 18.99% |
| Dec 31, 2015 | 716 | 42 | 6.23% |
| Dec 31, 2014 | 674 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| IQVIA Holdings | 93,000 |
| Labcorp Holdings | 71,000 |
| Quest Diagnostics | 57,000 |
| Agilent Technologies | 18,100 |
| Mettler-Toledo International | 18,100 |
| IDEXX Laboratories | 11,000 |
| Revvity | 11,000 |
| Illumina | 10,080 |
NTRA News
- 1 day ago - 20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera's Oncology Platform - Business Wire
- 8 days ago - Natera's Signatera Data Suggests Select Breast Cancer Patients Could Skip Surgery - Benzinga
- 8 days ago - SignateraTM MRD Identifies Breast Cancer Patients Who Can Forgo Surgery - Business Wire
- 23 days ago - Two Publications Highlight Clinical Utility of Signatera™ in Anal and Rectal Cancers - Business Wire
- 27 days ago - MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026 - PRNewsWire
- 27 days ago - Natera Announces Commercial Launch of Zenith™ Genomics for Rare Disease Diagnosis - Business Wire
- 5 weeks ago - Signatera™ MRD Data at ASCO GU Highlights Potential Utility Across GU Cancers, Including for Bladder Preservation - Business Wire
- 5 weeks ago - Natera Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire